Scand J Urol Nephrol
-
Scand J Urol Nephrol · Jan 2002
Case ReportsFournier's gangrene following penile self-injection with cocaine.
To date, there have been no reports of Fournier's gangrene following penile self-injection of cocaine. We report a case of cocaine-induced Fournier's gangrene requiring parenteral antibiotics followed by primary surgical debridement and delayed reconstructive procedure of penile skin.
-
Scand J Urol Nephrol · Jan 2002
Randomized Controlled Trial Comparative Study Clinical TrialComparison of three analgesics for extracorporeal shock wave lithotripsy.
The aim of the study was to compare the clinical efficacy of three different analgesic drugs with respect to their level of sedation, analgesia and quick mobilisation without cardiopulmonary depression, for outpatient extracorporeal shock wave lithotripsy (ESWL) procedure. ⋯ Diclofenac sodium and tramadol were found to be safe and effective analgesics with lower side-effects than fentanyl.
-
Scand J Urol Nephrol · Jan 2002
Comparative StudyCalculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Whether there is an association between the development of benign prostatic hyperplasia (BPH) and clinical prostate cancer is controversial. The present report tests the hypothesis of an association between BPH growth and the development of clinical prostate cancer by examining stage, grade and PSA-level in men with recently discovered clinical prostate cancer with slow or fast-growing BPH. If the hypothesis is true, men with fast-growing BPH would have a more advanced clinical prostate cancer. ⋯ This report confirms findings in previous studies that fast-growing BPH is a risk factor for NIDDM, hypertension, tallness, obesity, dyslipidaemia and hyperinsulinaemia. The present report extends this list of risk factors to include atherosclerotic disease manifestations, hyperuricaemia and higher ALAT levels. The study suggests that fast-growing BPH is a risk factor for developing clinical prostate cancer and, thus, supports the hypothesis of an association between the development of BPH and clinical prostate cancer. The study generates the hypothesis that clinical prostate cancer is a component of the metabolic syndrome and that insulin is a promoter of clinical prostate cancer.